Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Saliva Diagnostics delists from Nasdaq:

This article was originally published in Clinica

Executive Summary

Saliva Diagnostics has left the Nasdaq SmallCap market because it says it does not meet the new listing standards required by the market. The rapid diagnostics company plans to have itself listed on the OTC Bulletin Board in the near future. The company recently completed a private placement of 6% preferred stock at $1.5 million which is convertible into ordinary shares at the end of April.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT080928

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel